FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/03/064651 [Registered on: 22/03/2024] Trial Registered Prospectively
Last Modified On: 01/12/2024
Post Graduate Thesis  No 
Type of Trial  PMS 
Type of Study   Drug 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A study to compare whether oral baclofen or oral tizanidine is better in patients presenting with tightness of the upper limb after stroke. 
Scientific Title of Study   A study to compare efficacy of oral baclofen versus oral tizanidine in post stroke spasticity of upper limb. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DrSudipan Mitra 
Designation  Associate Professor,Department of General Medicine 
Affiliation  Jalpaiguri Government Medical College and d Hospital 
Address  Jalpaiguri Government Medical College and Hospital,Department of General Medicine,6th floor Superspeciality Building.

Jalpaiguri
WEST BENGAL
735101
India 
Phone  9836837658  
Fax    
Email  sudipanmitra_65@yahoo.com  
 
Details of Contact Person
Scientific Query
 
Name  DrSudipan Mitra 
Designation  Associate Professor,Department of General Medicine 
Affiliation  Jalpaiguri Government Medical College and d Hospital 
Address  Jalpaiguri Government Medical College and Hospital.Department of General Medicine,Superspeciality Building ,6th floor

Jalpaiguri
WEST BENGAL
735101
India 
Phone  9836837658  
Fax    
Email  sudipanmitra_65@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  DrSudipan Mitra 
Designation  Associate Professor,Department of General Medicine 
Affiliation  Jalpaiguri Government Medical College and d Hospital 
Address  Jalpaiguri Government Medical College and Hospital.Department of General Medicine,Superspeciality Building,6th floor.

Jalpaiguri
WEST BENGAL
735101
India 
Phone  9836837658  
Fax    
Email  sudipanmitra_65@yahoo.com  
 
Source of Monetary or Material Support  
Jalpaiguri Government Medical College and Hospital,Hospital Road,Jalpaiguri,West Bengal,Pin-735101 
 
Primary Sponsor  
Name  Jalpaiguri Government Medical College and Hospital 
Address  Hospital Road,Jalpaiguri,West Bengal,Pin-735101 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrAnkita Singha Roy  Jalpaiguri Government Medical College and Hospital  Department of Physical Medicine and Rehabilitation,1st floor Superspeciality Building,Hospital Road,Jalpaiguri,Pin 735101
Jalpaiguri
WEST BENGAL 
9933473616

ankusroy497@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Jalpaiguri Government Medical College and Hospital Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: G811||Spastic hemiplegia,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Oral baclofen  Oral anti-spastic drug used to reduce spasticity. Dose 30-50mg per day in divided doses for 6months orally 
Comparator Agent  Oral tizanidine  Oral anti-spastic drug used to reduce spasticity. Dose- 4-12mg per day in divided doses for 6 months orally  
 
Inclusion Criteria  
Age From  35.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  Non -diabetic 
 
ExclusionCriteria 
Details  Diabetic 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Modified Asthworth Scale for measurement of spasticity.Spasticity score of 2 and 3 were included.  Visit 0(First visit)
Visit 1(At 1 month)
Visit 2(At 3 months)
Visit 3(At 6 months) 
 
Secondary Outcome  
Outcome  TimePoints 
Action Research Arm Test for measurement of upper limb function.  Visit 0 (First visit)
Visit 1 (At 1 month)
Visit 2 (At 3 months)
Visit 3 (At 6 months) 
 
Target Sample Size   Total Sample Size="28"
Sample Size from India="28" 
Final Enrollment numbers achieved (Total)= "28"
Final Enrollment numbers achieved (India)="28" 
Phase of Trial   Post Marketing Surveillance 
Date of First Enrollment (India)   02/04/2024 
Date of Study Completion (India) 31/10/2024 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) 31/10/2024 
Estimated Duration of Trial   Years="0"
Months="0"
Days="9" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary
Modification(s)  
This is a prospective open label randomised control trial having two arms.One group of patient receives oral baclofen for spasticity of upper limb and other group receives oral tizanidine for spasticity of upper limb following a stroke.Outcomes measured ha been analyzed through proper statistical software. Both groups have shown comparable results. 
Close